
We envisage a world where the highest quality mental healthcare is available to everyone, everywhere. To get here, we use our unfair advantage in AI to solve the catastrophic supply-demand imbalance in mental healthcare. We come from neuroscience, machine learning, software engineering and psychology. Together, we're empowering patients and clinicians to tackle the leading cause of disability worldwide. It's time things changed.

We envisage a world where the highest quality mental healthcare is available to everyone, everywhere. To get here, we use our unfair advantage in AI to solve the catastrophic supply-demand imbalance in mental healthcare. We come from neuroscience, machine learning, software engineering and psychology. Together, we're empowering patients and clinicians to tackle the leading cause of disability worldwide. It's time things changed.
Headquarters: London; remote-first team
Founded: Around 2020
Product focus: Clinical AI for mental healthcare (Limbic Access, Limbic Care)
Recent funding: Series A $14M (Mar 2024) led by Khosla Ventures
Mental health care access, assessment, triage, and patient support
2020
Mental Health Care
$14,000,000
“Led by Khosla Ventures; other reported investors include Illusian Founder Office and Gaingels”
| Company |
|---|